Revised Recommendations for the Treatment of Infants Diagnosed with Spinal Muscular Atrophy Via Newborn Screening Who Have 4 Copies of SMN2

Jacqueline Glascock*, Jacinda Sampson, Anne M. Connolly, Basil T. Darras, John W. Day, Richard Finkel, R. Rodney Howell, Katherine W. Klinger, Nancy Kuntz, Thomas Prior, Perry B. Shieh, Thomas O. Crawford, Douglas Kerr, Jill Jarecki

*Corresponding author for this work

Research output: Contribution to journalLetterpeer-review

112 Scopus citations
Original languageEnglish (US)
Pages (from-to)97-100
Number of pages4
JournalJournal of neuromuscular diseases
Volume7
Issue number2
DOIs
StatePublished - 2020

Funding

BD: Serves on advisory boards for AveXis, Biogen, Vertex, Cytokinetics, Genentech, Roche, and Sarepta; grants from Cytokinetics, FibroGen, Ionis/Biogen Pharmaceuticals, Inc. (during ENDEAR, CHERISH, CS12, CS11), National Institutes of Health (National Institute of Neurological Disorders and Stroke), PTC, Sarepta, AveXis, Roche, Slaney Fund for SMA, SMA Foundation, and Summit.

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Cite this